1887

Chapter 2 : Pathogens of Rats and Mice

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Pathogens of Rats and Mice, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817824/9781555812669_Chap02-1.gif /docserver/preview/fulltext/10.1128/9781555817824/9781555812669_Chap02-2.gif

Abstract:

The observation that infectious diseases of laboratory rats and mice have been on the decline for decades could lead one to a general sense of complacency regarding the plethora of pathogens to which these animals are susceptible. This chapter presents a wide, although certainly not exhaustive, scope of natural pathogens of laboratory rats and mice, and their effects on host physiology. Potential research-altering effects of H-1 virus include hepatocellular necrosis in rats exposed to pathogens or chemicals causing liver injury; reduction of the incidence of -associated arthritis, although other copathogens could also be present; alteration of lipid metabolism; induction of a caspase-3-dependent apoptosis activation pathway in the cerebellum; and inhibition of human tumor cell growth in mice. All mice and rats should be certified free of all parvoviruses prior to entry into the animal facility. Sendai virus (SV) is one of the most important pathogens infecting laboratory mice and rats. is, without question, one of the most important pathogens infecting laboratory rats and mice, and is the cause of murine respiratory mycoplasmosis (MRM). The primary importance of Salmonella serotypes is as zoonotic agents and as pathogens in immunocompromised mice and rats. While many species of mites infest wild rodents, only three species of nonburrowing mites are commonly found on laboratory mice and rats. and infest mice, and infests rats.

Citation: Baker D. 2003. Pathogens of Rats and Mice, p 19-107. In Natural Pathogens of Laboratory Animals. ASM Press, Washington, DC. doi: 10.1128/9781555817824.ch2
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817824.chap2
1. Baker, D. G. 1998. Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin. Microbiol. Rev. 11: 231 266.
1. Blailock, Z. R.,, E. R. Rabin,, and J. L. Melnick. 1967. Adenovirus endocarditis in mice. Science 157: 69 70.
2. Cauthen, A. N.,, C. C. Brown,, and K. R. Spindler. 1999. In vitro and in vivo characterization of a mouse adenovirus type 1 early region 3 null mutant. J. Virol. 73: 8640 8646.
3. Charles, P. C.,, X. Chen,, M. S. Horwitz,, and C. F. Brosnan. 1999a. Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice. J. Neurovirol. 5: 55 64.
4. Charles, P. C.,, J. D. Guida,, C. F. Brosnan,, and M. S. Horwitz. 1998. Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice. Virology 245: 216 228.
5. Charles, P. C.,, K. S. Weber,, B. Cipriani,, and C. F. Brosnan. 1999b. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias. J. Neuroimmunol. 100: 64 73.
6. Einarsson, O.,, G. P. Geba,, Z. Zhu,, M. Landry,, and J. A. Elias. 1996. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J. Clin. Invest. 97: 915 924.
7. Ginder, D. R. 1964. Increased susceptibility of mice infected with mouse adenoviruses to Escherichia coli-induced pyelonephritis. J. Exp. Med. 120: 1117 1128.
8. Guida, J. D.,, G. Fejer,, L. A. Pirofski,, C. F. Brosnan,, and M. S. Horwitz. 1995. Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J. Virol. 69: 7674 7681.
9. Hamelin, C.,, and G. Lussier. 1988. Genotypic differences between the mouse adenovirus strains FL and K87. Experientia 44: 65 66.
10. Hartley, J. W.,, and W. P. Rowe. 1960. A new mouse virus apparently related to the adenovirus group. Virology 11: 645 647.
11. Hashimoto, K.,, T. Sugiyama,, M. Yoshikawa,, and S. Sasaki. 1970. Intestinal resistance in the experimental enteric infection of mice with a mouse adenovirus. I. Growth of the virus and appearance of a neutralizing substance in the intestinal tract. Jpn. J. Microbiol. 14: 381 395.
12. Heck, F. C., Jr., W. C. Sheldon, and C. A. Gleiser. 1972. Pathogenesis of experimentally produced mouse adenovirus infection in mice. Am. J. Vet. Res. 33: 841 846.
13. Kajon, A. E.,, C. C. Brown,, and K. R. Spindler. 1998. Distribution of mouse adenovirus type 1 in intraperitoneally and intranasally infected adult outbred mice. J. Virol. 72: 1219 1223.
14. Kring, S. C.,, C. S. King,, and K. R. Spindler. 1995. Susceptibility and signs associated with mouse adenovirus type 1 infection of adult outbred Swiss mice. J. Virol. 69: 8084 8088.
15. Kring, S. C.,, and K. R. Spindler. 1996. Lack of effect of mouse adenovirus type 1 infection on cell surface expression of major histocompatibility complex class I antigens. J. Virol. 70: 5495 5502.
16. Margolis, G.,, L. Kilham,, and E. M. Hoenig. 1974. Experimental adenovirus infection of the mouse adrenal gland. I. Light microscopic observations. Am. J. Pathol. 75: 363 372.
17. Markine-Goriaynoff, D.,, J. T. van der Logt,, C. Truyens,, T. D. Nguyen,, F. W. Heessen,, G. Bigaignon,, Y. Carlier,, and J. P. Coutelier. 2000. IFN- γ-independent IgG2a production in mice infected with viruses and parasites. Int. Immunol. 12: 223 230.
18. National Research Council. 1991. Infectious Diseases of Mice and Rats: a Report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. National Academy Press, Washington, D.C.
19. Smith, K.,, C. C. Brown,, and K. R. Spindler. 1998. The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice. J. Virol. 72: 5699 5706.
20. Spindler, K. R.,, L. Fang,, M. L. Moore,, G. N. Hirsch,, C. C. Brown,, and A. Kajon. 2001 SJL/J mice are highly susceptible to infection by mouse adenovirus type 1. J. Virol. 75: 12039 12046.
21. Takeuchi, A.,, and K. Hashimoto. 1976. Electron microscopy study of experimental enteric adenovirus infection in mice. Infect. Immun. 13: 569 580.
22. Umehara, K.,, M. Hirakawa,, and K. Hashimoto. 1984. Fluctuation of antiviral resistance in the intestinal tracts of nude mice infected with a mouse adenovirus. Microbiol. Immunol. 28: 679 690.
23. VanderVeen, J.,, and A. Mes. 1973. Experimental infection with mouse adenovirus in adult mice. Arch. Gesamte Virusforsch. 42: 235 241.
1. Berencsi, K.,, V. Endresz,, D. Klurfeld,, L. Kari,, D. Kritchevsky,, and E. Gonczol. 1998. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. Cell. Adhes. Commun. 5: 39 47.
2. Bolger, G.,, N. Lapeyre,, M. Rheaume,, P. Kibler,, C. Bousquet,, M. Garneau,, and M. Cordingley. 1999. Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis. Antivir. Res. 44: 155 165.
3. Booth, T. W.,, A. A. Scalzo,, C. Carrello,, P. A. Lyons,, H. E. Farrell,, G. R. Singleton,, and G. R. Shellam. 1993. Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch. Virol. 132: 209 220.
4. Bruggeman, C. A.,, H. Meijer,, P. H. J. Dormans,, W. M. H. Debie,, G. E. L. M. Grauls,, and C. P. A. van Boven. 1982. Isolation of a cytomegalovirus-like agent from wild rats. Arch. Virol. 73: 231 241.
5. Cassell, H. S.,, P. Price,, S. D. Olver,, and G. C. Yeoh. 1998. The association between murine cytomegalovirus induced hepatitis and the accumulation of oval cells. Int. J. Exp. Pathol. 79: 433 441.
6. Cavanaugh, V. J.,, L. G. Guidotti,, and F. V. Chisari. 1998. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J. Virol. 72: 2630 2637.
7. Collins, T.,, C. Pomeroy,, and M. C. Jordan. 1993. Detection of latent cytomegalovirus DNA in diverse organs of mice. J. Infect. Dis. 168: 725 729.
8. Cretney, E.,, M. A. Degli-Esposti,, E. H. Densley,, H. E. Farrell,, N. J. Davis-Poynter,, and M. J. Smyth. 1999. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 190: 435 444.
9. Dangler, C. A.,, S. F. Baker,, M. Kariuki Njenga,, and S. H. Chia. 1995. Murine cytomegalovirus- associated arteritis. Vet. Pathol. 32: 127 133.
10. Duan, Y.,, and S. S. Atherton. 1996. Immunosuppression induces transcription of murine cytomegalovirus glycoprotein H in the eye and at non-ocular sites. Arch. Virol. 141: 411 423.
11. Fairweather, D.,, C. M. Lawson,, A. J. Chapman,, C. M. Brown,, T. W. Booth,, J. M. Papadimitriou,, and G. R. Shellam. 1998. Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin. Immunology 94: 263 270.
12. Fleck, M.,, E. R. Kern,, T. Zhou,, B. Lang,, and J. D. Mountz. 1998. Murine cytomegalovirus induces a Sjogren’s syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis Rheum. 41: 2175 2184.
13. Furrarah, A. M.,, and C. Sweet. 1994. Studies of the pathogenesis of wild-type virus and six temperature-sensitive mutants of mouse cytomegalovirus. J. Med. Virol. 43: 317 330.
14. Goetz, L.,, and C. Pomeroy. 1996. Impact of prophylactic ganciclovir on bronchoalveolar lavage lymphocyte numbers and phenotypes in murine cytomegalovirus-induced reactivation of Toxoplasma pneumonia. J. Lab. Clin. Med. 128: 384 391.
15. Griffiths, M. M.,, C. B. Smith,, L. S. Wei,, and S. C. Ting-Yu. 1991. Effects of rat cytomegalovirus infection on immune functions in rats with collagen induced arthritis. J. Rheumatol. 18: 497 504.
16. Hamano, S.,, H. Yoshida,, H. Takimoto,, K. Sonoda,, K. Osada,, X. He,, Y. Minamishima,, G. Kimura,, and K. Nomoto. 1998. Role of macrophages in acute murine cytomegalovirus infection. Microbiol. Immunol. 42: 607 616.
17. Hangai, M.,, Y. Kaneda,, H. Tanihara,, and Y. Honda. 1996. In vivo gene transfer into the retina mediated by a novel liposome system. Investig. Ophthalmol. Vis. Sci. 37: 2678 2685.
18. Huber, B. T.,, P. N. Hsu,, and N. Sutkowski. 1996. Virus-encoded superantigens. Microbiol. Rev. 60: 473 482.
19. Inkinen, K.,, A. Soots,, L. Krogerus,, C. Bruggeman,, J. Ahonen,, and I. Lautenschlager. 2002. Cytomegalovirus increases collagen synthesis in chronic rejection in the rat. Nephrol. Dial. Transplant. 17: 772 779.
20. Karupiah, G.,, T. E. Sacks,, D. M. Klinman,, T. N. Fredrickson,, J. W. Hartley,, J. H. Chen,, and H. C. Morse, III. 1998. Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4_ T cells and CD40. Virology 240: 12 26.
21. Kloover, J. S.,, A. P. Soots,, L. A. Krogerus,, H. O. Kauppinen,, R. J. Loginov,, K. L. Holma,, C. A. Bruggeman,, P. J. Ahonen,, and I. T. Lautenschlager. 2000. Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1, vascular adhesion molecule-1, and their ligans leukocyte function antigen-1 and very late antigen-4 in the graft. Transplantation 27: 1641 2647.
22. Kloover, J. S.,, A. E. van den Bogaard,, J. G. van Dam,, G. E. Grauls,, C. Vink,, and C. A. Bruggeman. 2002. Persistent rat cytomegalovirus (RCMV) infection of the salivary glands contribute to the anti-RCMV humoral immune response. Virus Res. 85: 163 172.
23. Koskinen, P.,, K. Lemstrom,, H. Bruning,, M. Daemen,, C. Bruggeman,, and P. Hayry. 1995. Cytomegalovirus infection induces vascular wall inflammation and doubles arteriosclerotic changes in rat cardiac allografts. Transplant. Proc. 27: 574 575.
24. Kosugi, I.,, H. Kawasaki,, Y. Arai,, and Y. Tsutsui. 2002. Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons . Am. J. Pathol. 161: 919 928.
25. Lee, S. H.,, S. Girard,, D. Macina,, M. Busa,, A. Zafer,, A. Belouchi,, P. Gros,, and S. M. Vidal. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28: 42 45.
26. Mitchell, B. M.,, A. Leung,, and J. G. Stevens. 1996. Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes. Virology 223: 198 207.
27. Mori, T.,, K. Ando,, K. Tanaka,, Y. Ikeda,, and Y. Koga. 1997. Fas-mediated apoptosis of the hematopoietic progenitor cells in mice infected with murine cytomegalovirus. Blood 89: 3565 3573.
28. National Research Council. 1991. Infectious Diseases of Mice and Rats: a Report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. National Academy Press, Washington, D.C.
29. Ninomiya, T.,, H. Takimoto,, G. Matsuzaki,, S. Hamano,, H. Yoshido,, Y. Yoshikai,, G. Kimura,, and K. Nomoto. 2000. V γ1 + γδ T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon- γ. Immunology 99: 187 194.
30. O’Donoghue, H. L.,, C. M. Lawson,, and W. D. Reed. 1990. Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis . Immunology 71: 20 28.
31. Olver, S. D.,, and P. Price. 1998. Contrasting phenotypes of liver-infiltrating leucocytes isolated from MCMV-infected BALB/c and C57Bl/6 mice. Int. J. Exp. Pathol. 79: 33 46.
32. Osborn, J. E., 1982. Cytomegalovirus and other herpesviruses, p. 267 292. In H. L. Foster, , H. D. Small, , and J. G. Fox (ed.), The Mouse in Biomedical Research, vol. II. Diseases. Academic Press, New York, N.Y.
33. Palmon, A.,, S. Tel-or,, E. Shai,, B. Rager- Zisman,, and Y. Burstein. 2000. Development of a highly sensitive quantitative competitive PCR assay for the detection of murine cytomegalovirus DNA. J. Virol. 86: 107 114.
34. Peacock, C. D.,, and P. Price. 1999. The role of IL-12 in the control of MCMV is fundamentally different in mice with a retroviral immunodeficiency syndrome (MAIDS) . Immunol. Cell. Biol. 77: 131 138.
35. Pollock, J. L.,, and H. W. Virgin, IV. 1995. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney . J. Virol. 69: 1762 1768.
36. Price, P.,, S. D. Olver,, M. Silich,, T. Z. Nador,, S. Yerkovich,, and S. G. Wilson. 1996. Adrenalitis and the adrenocortical response of resistant and susceptible mice to acute murine cytomegalovirus infection. Eur. J. Clin. Invest. 26: 811 819.
37. Redpath, S.,, A. Angulo,, N. R. Gascoigne,, and P. Ghazal. 1999. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J. Immunol. 162: 6701 6707.
38. Ruzek, M. C.,, A. H. Miller,, S. M. Opal,, B. D. Pearce,, and C. A. Biron. 1997. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185: 1185 1192.
39. Shanley, J. D.,, R. S. Thrall,, and S. J. Forman. 1997. Murine cytomegalovirus replication in the lungs of athymic BALB/c nude mice. J. Infect. Dis. 175: 309 315.
40. Shinmura, Y.,, I. Kosugi,, M. Keneta,, and Y. Tsutsui. 1999. Migration of virus-infected neuronal cells in cerebral slice cultures of developing mouse brains after in vitro infection with murine cytomegalovirus. Acta Neuropathol 98: 590 596.
41. Stals, F. S.,, G. Steinhoff,, S. S. Wagenaar,, J. P. van Breda Vriesman,, A. Haverich,, P. Dormans,, F. Moeller,, and C. A. Bruggeman. 1996. Cytomegalovirus induces interstitial lung disease in allogeneic bone marrow transplant recipient rats independent of acute graft-versushost response. Lab. Invest. 74: 343 352.
42. Tay, C. H.,, and R. M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71: 267 275.
43. Tsutsui, Y.,, A. Kashiwai,, N. Kawamura,, S. Aiba-Masago,, and I. Kosugi. 1995. Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. Arch. Virol. 140: 1725 1736.
44. Wang, L. L.,, D. T. Chu,, A. O. Dokun,, and W. M. Yokoyama. 2000. Inducible expression of the gp49B inhibitory receptor on NK cells. J. Immunol. 164: 5215 5220.
45. Ziegler, H.,, W. Muranyi,, H. G. Burgert,, E. Kremmer,, and U. H. Koszinowski. 2000. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. EMBO J. 19: 870 881.
1. Born, T. L.,, L. A. Morrison,, D. J. Esteban,, T. VandenBos,, L. G Thebeau,, N. Chen,, M. K. Spriggs,, J. E. Sims,, and R. M. Buller. 2000. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J. Immunol. 164: 3246 3254.
2. Brownstein, D. G.,, and L. Gras. 1997. Differential pathogenesis of lethal mousepox in congenic DBA/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen. Am. J. Pathol. 150: 1407 1420.
3. Chen, N.,, R. M. Buller,, E. M. Wall,, and C. Upton. 2000. Analysis of host response modifier ORF’s of ectromelia virus, the causative agent of mousepox. Virus Res. 66: 155 173.
4. Delano, M. L.,, and D. G. Brownstein. 1995. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J. Virol. 69: 5875 5877.
5. Dick, E. J., Jr.,, C. L. Kittell, , H. Meyer, , P. L. Farrar, , S. L. Ropp, , J. J. Esposito, , R. M. L. Buller, , H. Neubauer, , Y. H. Kang, , and A. E. McKee. 1996. Mousepox outbreak in a laboratory mouse colony. Lab. Anim. Sci. 46: 602 611.
6. Fenner, F. 1981. Mousepox (Infectious ectromelia): past, present, and future. Lab. Anim. Sci. 31: 553 559.
7. Karupiah, G.,, R. M. Buller,, N. Van Rooijen,, C. J. Duarte,, and J. Chen. 1996. Different roles for CD4 + and CD8 + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70: 8301 8309.
8. Karupiah, G.,, J. H. Chen,, C. F. Nathan,, S. Mahalingam,, and J. D. MacMickling. 1998. Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection. J. Virol. 72: 7703 7706.
9. Gierynska, M.,, F. N. Toka,, I. S. Cespedes,, A. Schollenberger,, E. Malicka,, A. Popis,, and M. G. Niemialtowski. 2000. Homing studies on distribution of ectromelia (mousepox) virus-specific T cells adoptively transferred into syngeneic H-2d mice: paradigm of lymphocyte migration. Viral Immunol. 13: 107 123.
10. Lipman, N. S.,, S. Perkins,, H. Nguyen,, M. Pfeffer,, and H. Meyer. 2000. Mousepox resulting from use of ectromelia viruscontaminated, imported mouse serum. Comp. Med. 50: 426 435.
11. Mossman, K.,, C. Upton,, R. M. Buller,, and G. McFadden. 1995. Species specificity of ectromelia virus and vaccinia virus interferon- γ binding proteins. Virology 208: 762 769
12. Mullbacher, A.,, P. Waring,, R. Tha Hla,, T. Tran,, S. Chin,, T. Stehle,, C. Museteanu,, and M. M. Simon. 1999. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc. Natl. Acad. Sci. USA 96: 13950 13955.
13. National Research Council. 1991. Infectious Diseases of Mice and Rats: a Report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. National Academy Press, Washington, D.C.
14. Neubauer, H.,, M. Pfeffer,, and H. Meyer. 1997. Specific detection of mousepox virus by polymerase chain reaction. Lab. Anim. 31: 201 205.
15. Niemialtowski, M. G.,, I. Spohr de Faundez,, M. Gierynska,, E. Malicka,, F. N. Toka,, A. Schollenberger,, and A. Popis. 1994. The inflammatory and immune response to mousepox (infectious ectromelia) virus. Acta Virol. 38: 299 307.
16. Senkevich, T. G.,, E. V. Koonin,, and R. M. Buller. 1994. A poxvirus protein with a RING zinc finger motif is of crucial importance for virulence. Virology 198: 118 128.
17. Smith, V. P.,, and N. A. Alcami. 2000. Expression of secreted cytokine and chemokine inhibitors by ectromelia virus. J. Virol. 74: 8460 .
18. Smith, V. P.,, N. A. Bryant,, and A. Alcami. 2000. Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J. Gen. Virol. 81: 1223 1230.
19. Toka, F. N.,, M. G. Niemialtowski,, I. Spohr de Faundez,, and M. Gierynska. 1996. Cytotoxic T lymphocyte control during ectromelia (mousepox) virus infection: interaction between MHC-restricted cells analyzed by non-radioactive fluorometry. Acta Virol. 40: 239 244.
1. Besselsen, D. G.,, C. L. Besch-Williford,, D. J. Pintel,, C. L. Franklin,, R. R. Hook, Jr., and L. K. Riley. 1995. Detection of H-1 parvovirus and Kilham rat virus by PCR. J. Clin. Microbiol. 33: 1699 1703.
2. Faisst, S.,, D. Guittard,, A. Benner,, J. Y. Cesbron,, J. R. Schlehofer,, J. Rommelaere,, and T. Dupressoir. 1998. Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection. Int. J. Cancer 75: 584 589.
3. Gripenberg-Lerche, C.,, and P. Toivanen. 1993. Yersinia associated arthritis in SHR rats: effect of the microbial status of the host. Ann. Rheum. Dis. 52: 223 228.
4. Jacoby, R. O.,, L. Ball-Goodrich,, D. G. Besselsen,, M. D. McKisic,, L. K. Riley,, and A. L. Smith. 1996. Rodent parvovirus infections. Lab. Anim. Sci. 46: 370 380.
5. Kraft, V.,, and B. Meyer. 1990. Seromonitoring in small laboratory animal colonies. A five year survey: 1984-1988. Z. Verstierkd. 33: 29 35.
6. National Research Council. 1991. Infectious Diseases of Mice and Rats: a Report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. National Academy Press, Washington, D.C.
7. Ohshima, T.,, M. Iwama,, Y. Ueno,, F. Sugiyama,, T. Nakajima,, A. Fukamizu,, and K. Yagami. 1998. Induction of apoptosis in vitro and in vivo by H-1 parvovirus infection. J. Gen. Virol. 79: 3067 3071.
8. Ran, Z.,, B. Rayet,, J. Rommelaere,, and S. Faisst. 1999. Parvovirus H-1-induced cell death: influence of intracellular NAD consumption on the regulation of necrosis and apoptosis. Virus Res. 65: 161 174.
9. Ruffolo, P. R.,, G. Margolis,, and L. Kilham. 1966. The induction of hepatitis by prior partial hepatectomy in resistant adult rats injected with H-1 virus. Light and electron microscopy and virologic studies. Am. J. Pathol. 49: 795 824.
10. Schuster, G. S.,, G. B. Caughman,, and N. L. O’Dell. 1991. Altered lipid metabolism in parvovirus- infected cells. Microbios 66: 143 155.
11. Van Pachterbeke, C.,, M. Tuynder,, A. Brandenburger,, G. Leclercq,, M. Borras,, and J. Rommelaere. 1997. Varying sensitivity of human mammary carcinoma cells to the toxic effect of parvovirus H-1. Eur. J. Cancer 33: 1648 1653.
12. Zenner, L.,, and J. P. Regnault. 2000. Tenyear long monitoring of laboratory mouse and rat colonies in French facilities: a retrospective study. Lab. Anim. 34: 76 83.
1. Chung, Y. H.,, H. S. Jun,, Y. Kang,, K. Hirasawa,, B. R. Lee,, N. Van Rooijen,, and J. W. Yoon. 1997. Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats. J. Immunol. 159: 466 471.
2. Chung, Y. H.,, H. S. Jun,, M. Son,, M. Bao,, H. Y. Bae,, Y. Kang,, and J. W. Yoon. 2000. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J. Immunol. 165: 2866 2876.
3. Coleman, G. L.,, R. O. Jacoby,, P. N. Bhatt,, A. L. Smith,, and A. M. Jonas. 1983. Naturally occurring lethal parvovirus infection in juvenile and young adult rats. Vet. Pathol. 20: 44 45.
4. Gabaldon, M.,, C. Capdevila,, and A. Zuniga. 1992. Effect of spontaneous pathology and thrombin on leukocyte adhesion to rat aortic endothelium. Atherosclerosis 93: 217 228.
5. Gaertner, D. J.,, R. O. Jacoby,, E. A. Johnson,, F. X. Paturzo,, and A. L. Smith. 1995. Persistent rat virus infection in juvenile athymic rats and its modulation by antiserum. Lab. Anim. Sci. 45: 249 253.
6. Gripenberg-Lerche, C.,, and P. Toivanen. 1993 . Yersinia associated arthritis in SHR rats: effect of the microbial status of the host. Ann. Rheum. Dis. 52: 223 228.
7. Jacoby, R. O.,, L. Ball-Goodrich,, D. G. Besselsen,, M. D. McKisic,, L. K. Riley,, and A. L. Smith. 1996. Rodent parvovirus infections. Lab. Anim. Sci. 46: 370 380.
8. Jacoby, R. O., National Research Council. 1991. Infectious Diseases of Mice and Rats: a Report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. National Academy Press, Washington, D.C.
9. Nicklas, W.,, V. Kraft,, and B. Meyer. 1993. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab. Anim. Sci. 43: 296 300.
10. Schuster, G. S.,, G. B. Caughman,, and N. L. O’Dell. 1991. Altered lipid metabolism in parvovirus-infected cells. Microbios 66: 143 155.
1. Anderson, G. W.,, G. A. Palmer,, R. R. Rowland,, C. Even,, and P. G. Plagemann. 1995. Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons. J. Gen. Virol. 76: 581 592.
2. Anderson, G. W.,, R. R. Rowland,, G. A. Palmer,, C. Even,, and P. G. Plagemann. 1995. Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers, concomitant with polyclonal activation of B cells. J. Virol. 69: 5177 5188.
3. Chen, Z.,, K. Li,, and P. G. Plagemann. 2000. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein. Virology 266: 88 98.
4. Chen, Z.,, R. R. Rowland,, G. W. Anderson,, G. A. Palmer,, and P. G. Plagemann. 1997. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection. J. Virol. 71: 2913 2920.
5. Coutelier, J. P.,, J. Van Broeck,, and S. F. Wolf. 1995. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69: 1955 1958.
6. Even, C.,, R. R. Rowland,, and P. G. Plagemann. 1995. Cytotoxic T cells are elicited during acute infection of mice with lactate dehydrogenase-elevating virus but disappear during the chronic phase of infection . J. Virol. 69: 5666 5676.
7. Even, C.,, R. R. Rowland,, and P. G. Plagemann. 1995. Mouse hepatitis virus infection of mice causes long-term depletion of lactate dehydrogenase-elevating virus-permissive macrophages and T lymphocyte alterations. Virus Res. 39: 355 364
8. Faaberg, K. S.,, G. A. Palmer,, C. Even,, G. W. Anderson,, and P. G. Plagemann. 1995. Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase-elevating virus that differ in neuropathogenicity . Virus Res. 39: 331 340.
9. Gomez, K. A.,, J. Coutelier,, P. A. Mathieu,, L. Lustig,, and L. A. Retegui. 2000. Autoantibodies to cryptic epitopes elicited by infection with lactate dehyrogenase-elevating virus. Scand. J. Immunol. 51: 447 453.
10. Gomez, K. A.,, J. P. Coutelier,, and L. A. Retegui. 1997. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus. Scand. J. Immunol. 46: 168 174.
11. Goto, K.,, A. Takakura,, M. Yoshimura,, Y. Ohnishi,, and T. Itoh. 1998. Detection and typing of lactate dehydrogenase-elevating virus RNA from transplantable tumors, mouse liver tissues, and cell lines, using polymerase chain reaction. Lab. Anim. Sci. 48: 99 102.
12. Hayashi, T.,, S. Hashimoto,, and A. Kawashima. 1994. Effect of infection by lactic dehydrogenase virus on expression of intercellular adhesion molecule-1 on vascular endothelial cells of pancreatic islets in streptozotocin-induced insulitis of CD-1 mice. Int. J. Exp. Pathol. 75: 211 217.
13. Hayashi, T.,, H. Iwata,, T. Hasegawa,, M. Ozaki,, H. Yamamoto,, and T. Onodera. 1991. Decrease in neutrophil migration induced by endotoxin and suppression of interleukin-1 production by macrophages in lactic dehydrogenase virus-infected mice. J. Comp. Pathol. 104: 161 170.
14. Hayashi, T.,, Y. Koike,, T. Hasegawa,, M. Tsurudome,, M. Ozaki,, H. Yamamoto,, and T. Onodera. 1991. Inhibition of contact sensitivity by interferon in mice infected with lactic dehydrogenase virus. J. Comp. Pathol. 104: 357 366.
15. Hayashi, T.,, T. Onodera,, and H. Yamamoto. 1992. Detection of the binding of IgG2a and IgG2b on the surface of macrophages from mice chronically infected with lactic dehydrogenase virus. J. Comp. Pathol. 107: 35 40.
16. Hayashi, T.,, M. Ozaki,, Y. Ami,, T. Onodera,, and H. Yamamoto. 1992. Increased superoxide anion release by peritoneal macrophages in mice with a chronic infection of lactic dehydrogenase virus. J. Comp. Pathol. 106: 93 98.
17. Kameyama, Y.,, and T. Hayashi. 1994. Suppression of development of glomerulonephritis in NZB_NZWF1 mice by persistent infection with lactic dehydrogenase virus: relations between intercellular adhesion molecule-1 expression on endothelial cells and leucocyte accumulation in glomeruli. Int. J. Exp. Pathol. 75: 295 304.
18. Lawson, C. M. 2000. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell. Mol. Life Sci. 57: 552 560.
19. Li, K.,, T. Schuler,, Z. Chen,, G. E. Glass,, J. E. Childs,, and P. G. Plagemann. 2000. Isolation of lactate dehydrogenase-elevating viruses from wild house mice and their biological and molecular characterization. Virus Res. 67: 153 162.
20. Lipman, N. S.,, K. Henderson,, and W. Shek. 2000. False negative results using RT-PCR for detection of lactate dehydrogenase-elevating virus in a tumor cell line. Comp. Med. 50: 255 256.
21. Markine-Goriaynoff, D.,, J. T. van der Logt,, C. Truyens,, T. D. Nguyen,, F. W. Heessen,, G. Bigaignon,, Y. Carlier,, and J. P. Coutelier. 2000. IFN- γ-independent IgG2a production in mice infected with viruses and parasites. Int. Immunol. 12: 223 230.
22. Meite, M.,, S. Leonard,, M. E. Idrissi,, S. Izui,, P. L. Masson,, and J. P. Coutelier. 2000. Exacerbation of autoantibody-mediated hemolytic anemia by viral infection. J. Virol. 74: 6045 6049.
23. Monteyne, P.,, P. G. Coulie,, and J. P. Coutelier. 2000. Analysis of the Fv1 alleles involved in the susceptibility of mice to lactate dehydrogenase-elevating virus-included polioencephalomyelitis. J. Neurovirol. 6: 89 93
24. Monteyne, P.,, M. Meite,, and J.P. Coutelier. 1997. Involvement of CD4 + cells in the protection of C58 mouse against polioencephalomyelitis induced by lactate dehydrogenase-elevating virus. J. Neurovirol. 3: 380 384.
25. Mori, I.,, T. Hayashi,, S. Kitazima,, and H. Yamamoto. 1992. Binding of asparaginase to mouse monocytes. Int. J. Exp. Pathol. 73: 585 592.
26. National Research Council. 1991 Infectious Diseases of Mice and Rats: a Report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. National Academy Press, Washington, D.C.
27. Nicklas, W.,, V. Kraft,, and B. Meyer. 1993. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab. Anim. Sci. 43: 296 300.
28. Ohnishi, Y.,, M. Yoshimura,, and Y. Ueyama. 1995. Lactic dehydrogenase virus (LDHV) contamination in human tumor xenografts and its elimination. J. Natl. Cancer Inst. 87: 538 539.
29. Schlenker, E. H.,, Q. A. Jones,, R. R. Rowland,, M. Steffen-Bien,, and W. A. Cafruny. 2001. Age-dependent poliomyelitis in mice is associated with respiratory failure and viral replication in the central nervous system and lung. J. Neurovirol. 7: 265 271.
30. vandenBroek, M. F.,, R. Sporri,, C. Even,, P. G. Plagemann,, E. Hanseler,, H. Hengartner,, and R. M. Zinkernagel. 1997. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity. J. Immunol. 159: 1585 1588.
31. Zitterkopf, N. L.,, T. R. Haven,, M. Huela,, D. S. Bradley,, and W. A. Cafruny. 2002. Transplacental lactate dehyrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression. Placenta 23: 438 446.
1. Bartholdy, C.,, J. P. Christensen,, D. Wodarz,, and A. R. Thomsen. 2000. Persistent virus infection despite chronic cytotoxic Tlymphocyte activation in gamma interferondeficient mice infected with lymphocytic choriomeningitis virus. J. Virol. 74: 10304 10311.
2. Barton, L. L.,, and N. J. Hyndman. 2000. Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen. Pediatrics 105: E35.
3. Binder, D.,, J. Fehr,, H. Hengartner,, and R. M. Zinkernagel. 1997. Virus-induced transient bone marrow aplasia: major role of interferon- α/ β during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185: 517 530.
4. Borrow, P.,, C. F. Evans,, and M. B. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virusinfected dendritic cells results in generalized immune suppression. J. Virol. 69: 1059 1070.
5. Christensen, J. P.,, J. Johansen,, O. Marker,, and A. R. Thomsen. 1995. Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation. Clin. Exp. Immunol. 102: 268 273.
6. Ciurea, A.,, P. Klenerman,, L. Hunziker,, E. Horvath,, B. Odermatt,, A. F. Ochsenbein,, H. Hengartner,, and R. M. Zinkernagel. 1999. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. Proc. Natl. Acad. Sci. USA 96: 11964 11969.
7. Colle, J. H.,, M. F. Saron,, and P. Truffa-Bachi. 1993. Altered cytokine genes expression by conA-activated spleen cells from mice infected by lymphocytic choriomeningitis virus. Immunol. Lett. 35: 247 253.
8. de la Torre, J. C.,, M. Mallory,, M. Brot,, L. Gold,, G. Koob,, M. B. Oldstone,, and E. Masliah. 1996. Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells. Virology 220: 508 515.
9. Dykewicz, C. A.,, V. M. Dato,, S. P. Fisher-Hoch,, M. V. Howarth,, G. I. Perez-Oronoz,, S. M. Ostroff, , H. Gary, Jr.,. L. B. Schonberger, , and J. B. McCormick. 1992. Lymphocytic choriomeningitis outbreak associated with nude mice in a research institute. JAMA 267: 1349 1353.
10. El Azami El Idrissi, M.,, G. Mazza,, P. Monteyne,, C. J. Elson,, M. J. Day,, C. J. Pfau,, and J. P. Coutelier. 1998. Lymphocytic choriomeningitis virus-induced alterations of T helpermediated responses in mice developing autoimmune hemolytic anemia during the course of infection. Proc. Soc. Exp. Biol. Med. 218: 349 356.
11. Gold, L. H.,, M. D. Brot,, I. Polis,, R. Schroeder,, A. Tishon,, J. C. de la Torre,, M. B. Oldstone,, and G. F. Koob. 1994. Behavioral effects of persistent lymphocytic choriomeningitis virus infection in mice. Behav. Neural Biol. 62: 100 109.
12. Gossmann, J.,, J. Lohler,, O. Utermohlen,. and F. Lehmann-Grube. 1995. Murine hepatitis caused by lymphocytic choriomeningitis virus. II. Cells involved in pathogenesis. Lab. Invest. 72: 559 570.
13. Guidotti, L. G.,, P. Borrow,, M. V. Hobbs,, B. Matzke,, I. Gresser,, M. B. Oldstone,, and F. V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA 93: 4589 4594.
14. Kagi, D.,, and H. Hengartner. 1996. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 8: 472 477.
15. Kagi, D.,, P. Seiler,, J. Pavlovic,, B. Ledermann,, K. Burki,, R. M. Zinkernagel,, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25: 3256 3262.
16. Mazza, G.,, M. E. el Idrissi,, J. P. Coutelier,, A. Corato,, C. J. Elson,, C. J. Pfau,, and M. J. Day. 1997. Infection of C3HeB/FeJ mice with the docile strain of lymphocytic choriomeningitis virus induces autoantibodies specific for erythrocyte Band 3. Immunology 91: 239 245.
17. Morita, C.,, K. Tsuchiya,, H. Ueno,, Y. Muramatsu,, A. Kojimahara,, H. Suzuki,, N. Miyashita,, K. Moriwaki,, M. L. Jin,, X. L. Wu,, and F. S. Wang. 1996. Seroepidemiological survey of lymphocytic choriomeningitis virus in wild house mice in China with particular reference to their subspecies. Microbiol. Immunol. 40: 313 315.
18. Moskophidis, D.,, M. Battegay,, M. van den Broek,, E. Laine,, U. Hoffmann-Rohrer,, and R. M. Zinkernagel. 1995. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J. Gen. Virol. 76: 381 391.
19. National Research Council. 1991. Infectious Diseases of Mice and Rats: a Report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. National Academy Press, Washington, D.C.
20. Nicklas, W.,, V. Kraft,, and B. Meyer. 1993. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab. Anim. Sci. 43: 296 300.
21. Orange, J. S.,, and C. A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN- γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156: 1138 1142.
22. Ou, R.,, S. Zhou,, L. Huang,, and D. Moskophidis. 2001. Critical role for α/ β and γ interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75: 8407 8423.
23. Peacock, C. D.,, M. Y. Lin,, J. R. Ortaldo,, and R. M. Welsh. 2000. The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8 +T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2. J. Virol. 74: 7032 7038.
24. Percy, D. H.,, and S. W. Barthold. 2001. Pathology of Laboratory Rodents and Rabbits, 2nd ed. Iowa State University Press, Ames.
25. Rai, S. K.,, D. S. Cheung,, M. S. Wu,, T. F. Warner,, and M. S. Salvato. 1996. Murine infection with lymphocytic choriomeningitis virus following gastric inoculation. J. Virol. 70: 7213 7218.
26. Slifka, M. K.,, and R. Ahmed. 1996. Longterm antibody production is sustained by antibody- secreting cells in the bone marrow following acute viral infection. Ann. N. Y. Acad. Sci. 797: 166 176.
27. Spence, P. M.,, V. Sriram,, L. Van Kaer,, J. A. Hobbs,, and R. R. Brutkiewicz. 2001. Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression. Immunology 104: 168 174.
28. Sydora, B. C.,, B. D. Jamieson,, R. Ahmed,, and M. Kronenberg. 1996. Intestinal intraepithelial lymphocytes respond to systemic lymphocytic choriomeningitis virus infection. Cell. Immunol. 167: 161 169.
29. Varga, S. M.,, and R. M. Welsh. 2000. High frequency of virus-specific interleukin-2- producing CD4 + T cells and Th1 dominance during lymphocytic choriomeningitis virus infection. J. Virol. 74: 4429 4432.
1. Besselsen, D. G.,, D. J. Pintel,, G. A. Purdy,, C. L. Besch-Williford,, C. L. Franklin, , R. R. Hook, Jr.,, and L. K. Riley. 1996. Molecular characterization of newly recognized rodent parvoviruses. J. Gen. Virol. 77: 899 911.
2. Besselsen, D. G.,, A. M. Wagner,, and J. K. Loganbill. 2000. Effect of mouse strain and age on detection of Mouse Parvovirus 1 by use of serologic testing and polymerase chain reaction analysis. Comp. Med. 50: 498 502.
3. Brownstein, D. G.,, A. L. Smith,, R. O. Jacoby,, E. A. Johnson,, G. Hansen,, and P. Tattersall. 1991. Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab. Invest. 65: 357 364.
4. Colomar, M. C.,, B. Hirt,, and P. Beard. 1998. Two segments in the genome of the immunosuppressive minute virus of mice determine the host-cell specificity, control viral DNA replication and affect viral RNA metabolism. J. Gen. Virol. 79: 581 586.
5. Hansen, G. M.,, F. X. Paturzo,, and A. L. Smith. 1999. Humoral immunity and protection of mice challenged with homotypic or heterotypic parvovirus. Lab. Anim. Sci. 49: 380 384.
6. Jacoby, R. O.,, E. A. Johnson,, L. Ball-Goodrich,, A. L. Smith,, and M. D. McKisic. 1995. Characterization of mouse parvovirus infection by in situ hybridization. J. Virol. 69: 3915 3919.
7. Kapil, S. 1995. Minute virus of mice (MVM) nucleic acid production in susceptible and resistant strains of mice and F1 hybrids. Comp. Immunol. Microbiol. Infect. Dis. 18: 245 252.
8. National Research Council. 1991. Infectious Diseases of Mice and Rats: a Report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. National Academy Press, Washington, D.C.
9. Nicklas, W.,, V. Kraft,, and B. Meyer. 1993. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab. Anim. Sci. 43: 296 300.
10. Ramirez, J. C.,, A. Fairen,, and J. M. Almendral. 1996. Parvovirus minute virus of mice strain I multiplication and pathogenesis in the newborn mouse brain are restricted to proliferative areas and to migratory cerebellar young neurons. J. Virol. 70: 8109 8116.
11. Redig, A. J.,, and D. G. Besselsen. 2001. Detection of rodent parvoviruses by use of fluorogenic nuclease polymerase chain reaction assays. Comp. Med. 51: 326 331.
12. Segovia, J. C.,, J. A. Bueren,, and J. M. Almendral. 1995. Myeloid depression follows infection of susceptible newborn mice with the parvovirus minute virus of mice (strain I). J. Virol. 69: 3229 3232.
13. Segovia, J. C.,, J. M. Gallego,, J. A. Bueren,, and J. M. Almendral. 1999. Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice. J. Virol. 73: 1774 1784.
14. Zenner, L.,, and J. P. Regnault. 2000. Tenyear long monitoring of laboratory mouse and rat colonies in French facilities: a retrospective study. Lab. Anim. 34: 76 83.
1. Barthold, S. W.,, D. S. Beck,, and A. L. Smith. 1993. Enterotropic coronavirus (mouse hepatitis virus) in mice: influence of host age and strain on infection and disease. Lab. Anim. Sci. 43: 276 284.
2. Barthold, S. W.,, and A. L. Smith. 1992. Viremic dissemination of mouse hepatitis virusJHM following intranasal inoculation of mice. Arch. Virol. 122: 35 44.
3. Belyavskyi, M.,, E. Belyavskaya,, G. A. Levy,, and J. L. Leibowitz. 1998. Coronavirus MHV-3-induced apoptosis in macrophages. Virology 250: 41 49.
4. Belyavskyi, M.,, G. A. Levy,, and J. L. Leibowitz. 1998. The pattern of induction of apoptosis during infection with MHV-3 correlates with strain variation in resistance and susceptibility to lethal hepatitis. Adv. Exp. Med. Biol. 440: 619 625.
5. Besselsen, D. G.,, A. M. Wagner,, and J. K. Loganbill. 2002. Detection of rodent coronaviruses by sue of fluorogenic reverse transcriptasepolymerase chain reaction analysis. Comp. Med. 52: 111 116.
6. Braunwald, J.,, H. Nonnenmacher,, C. A. Pereira,, and A. Kirn. 1991. Increased susceptibility to mouse hepatitis virus type 3 (MHV3) infection induced by a hypercholesterolaemic diet with increased adsorption of MHV3 to primary hepatocyte cultures. Res. Virol. 142: 5 15.
7. Casebolt, D. B.,, B. Qian,, and C. B. Stephensen. 1997. Detection of enterotropic mouse hepatitis virus fecal excretion by polymerase chain reaction. Lab. Anim. Sci. 47: 6 10.
8. Chen, B. P.,, and T. E. Lane. 2002. Lack of nitric oxide synthase type 2 (NOS2) results in reduced neuronal apoptosis and mortality following mouse hepatitis virus infection of the central nervous system. J. Neurovirol. 8: 58 63.
9. Cray, C.,, M. O. Mateo,, and N. H. Altman. 1993. In vitro and long-term in vivo immune dysfunction after infection of BALB/c mice with mouse hepatitis virus strain A59. Lab. Anim. Sci. 43: 169 174.
10. de Souza, M. S.,, A. L. Smith,, and K. Bottomly. 1991. Infection of BALB/cByJ mice with the JHM strain of mouse hepatitis virus alters in vitro splenic T cell proliferation and cytokine production. Lab. Anim. Sci. 41: 99 105.
11. Ding, J. W.,, Q. Ning,, M. F. Liu,, A. Lai,, K. Peltekian,, L. Fung,, C. Holloway,, H. Yeger,, M. J. Phillips,, and G. A. Levy. 1998. Expression of the fg12 and its protein product (prothrombinasse) in tissues during murine hepatitis virus strain-3 (MHV-3) infection. Adv. Exp. Med. Biol. 440: 609 618.
12. Dufour, J. H.,, M. Dziejman,, M. T. Liu,, J. H. Leung,, T. E. Lane,, and A. D. Luster. 2002. IFN- γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168: 3195 3204.
13. Even, C.,, R. R. Rowland,, and P. G. Plagemann. 1995. Mouse hepatitis virus infection of mice causes long-term depletion of lactate dehydrogenase-elevating virus-permissive macrophages and T lymphocyte alterations. Virus Res. 39: 355 364.
14. Fallon, M. T., , W. H. Benjamin, Jr.,, T. R. Schoeb, , and D. E. Briles. 1991. Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth. Infect. Immun. 59: 852 856.
15. Gagne, S.,, L. Thibodeau,, and L. Lamontagne. 1998. Clonal deletion of some V beta β T cells in peripheral lymphocytes from C57BL/6 mice infected with MHV3. Adv. Exp. Med. Biol. 440: 485 489.
16. Godfraind, C.,, K. V. Holmes,, and J. P. Coutelier. 1995. Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice. J. Virol. 69: 6541 6547.
17. Godfraind, C.,, S. G. Langreth,, C. B. Cardellichio,, R. Knobler,, J. P. Coutelier,, M. Dubois-Dalcq,, and K. V. Holmes. 1995. Tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as a receptor for mouse hepatitis virus. Lab. Invest. 73: 615 627.
18. Glass, W. G.,, B. P. Chen,, M. T. Liu,, and T. E. Lane. 2002. Mouse hepatitis virus infection of the central nervous system: chemokinemediated regulation of host defense and disease. Virol. Immunol. 15: 261 272.
19. Homberger, F. R. 1997. Enterotropic mouse hepatitis virus. Lab. Anim. Sci. 31: 97 115.
20. Homberger, F. R.,, and S. W. Barthold. 1992. Passively acquired challenge immunity to enterotropic coronavirus in mice. Arch. Virol. 126: 35 43.
21. Homberger, F. R.,, S. W. Barthold,, and A. L. Smith. 1992. Duration and strainspecificity of immunity to enterotropic mouse hepatitis virus. Lab. Anim. Sci. 42: 347 351.
22. Homberger, F. R.,, and P. E. Thomann. 1994. Transmission of murine viruses and mycoplasma in laboratory mouse colonies with respect to housing conditions. Lab. Anim. 28: 113 120.
23. Hooks, J. J.,, C. Percopo,, Y. Wang,, and B. Detrick. 1993. Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy. J. Immunol. 151: 3381 3389.
24. Huang, D. S.,, S. N. Emancipator,, D. R. Fletcher,, M. E. Lamm,, and M. B. Mazanec. 1996. Hepatic pathology resulting from mouse hepatitis virus S infection in severe combined immunodeficiency mice. Lab. Anim. Sci. 46: 167 173.
25. Jolicoeur, P.,, and L. Lamontagne. 1995. Impairment of bone marrow pre-B and B cells in MHV3 chronically-infected mice. Adv. Exp. Med. Biol. 380: 193 195.
26. Komurasaki, Y.,, C. N. Nagineni,, Y. Wang,, and J. J. Hooks. 1996. Virus RNA persists within the retina in coronavirus-induced retinopathy. Virology 222: 446 450.
27. Kyuwa, S. 1997. Replication of murine coronaviruses in mouse embryonic stem cell lines. Exp. Anim. 46: 311 313.
28. Kyuwa, S.,, K. Machii,, A. Okumura,, and Y. Toyoda. 1996. Characterization of T cells expanded in vivo during primary mouse hepatitis virus infection in mice. J. Vet. Med. Sci. 58: 431 437.
29. Kyuwa, S.,, K. Machii,, and S. Shibata. 1996. Role of CD4 + and CD8 + T cells in mouse hepatitis virus infection in mice. Exp. Anim. 45: 81 83.
30. Lamontagne, L.,, S. Lusignan,, and C. Page. 2001. Recovery from mouse hepatitis virus infection depends on recruitment of CD8_ cells rather than activation of intrahepatic CD4 + α β TCRinter or NK T cells. Clin. Immunol. 101: 345 356.
31. Lardans, V.,, C. Godfraind,, J. T. van der Logt,, W. A. Heessen,, M. D. Gonzalez,, and J. P. Coutelier. 1996. Polyclonal B lymphocyte activation induced by mouse hepatitis virus A59 infection. J. Gen. Virol. 77: 1005 1009.
32. Lavi, E.,, Q. Wang,, S. R. Weiss,, and N. K. Gonatas. 1996. Syncytia formation induced by coronavirus infection is associated with fragmentation and rearrangement of the Golgi apparatus. Virology 221: 325 334.
33. Lee, S. K.,, H. Y. Youn,,